Fighting colorectal cancer and its drug resistance with the resources of the flora of Africa

Victor Kuete
DOI: https://doi.org/10.1016/bs.abr.2023.12.002
2024-01-17
Advances in Botanical Research
Abstract:Colorectal cancer (CRC) is a global health concern and is recognized as the third most common cancer and the second leading cause of cancer-related deaths. The major concern for clinical outcomes of CRC is the therapy resistance. In the present report, data on the cytotoxicity of the botanicals and phytochemicals from African medicinal plants against both drug sensitive and recalcitrant CRC cell lines were collected from scientific databases such as PubMed, ScienceDirect, Scopus, Web of Science, and Scholar Google. Using a well-elaborated classification method, we identified the most prominent African plants and their derived constituents that could be useful to combat CRC and its drug resistance. The botanical identified as the more suitable to fight the multidrug resistance of CRC cell lines were those from Echinops giganteus, Uapaca togoensis, Curcuma longa, Physalis peruviana, Ambrosia maritima, Beilschmiedia acuta, Polyscias fulva, and Nauclea pobeguinii while the most suitable compounds were canniflavone ( 6 ), 6 α -hydroxyphaseollidin ( 8 ), soyauxinium chloride ( 10 ), 7,7′′-di-O-methylchamaejasmin ( 12 ), ardisiacrispin B ( 14 ), 4′-hydroxy-2′,6′-dimethoxychalcone ( 15 ), aridanin ( 16 ), sophorapterocarpan A ( 19 ), epunctanone ( 20 ), hydnocarpin ( 22 ), guttiferone E ( 23 ), olean-12-en-3- ß-O - D -glucopyranoside ( 24 ), 3- O-ß - D -glucopyranosyl-(1-6)- ß- D -glucopyranosylurs-12-en-28-oic acid ( 25 ), isoneorautenol ( 26 ), and poinsettifolin B ( 27 ). These natural products deserve further investigations to produce novel medicine to efficiently combat CRC.
plant sciences
What problem does this paper attempt to address?